This comprehensive guide explores the application of Random Forest machine learning algorithms in constructing diagnostic models from complex metabolic biomarker data.
This article provides a comprehensive analysis of the SReFT-ML (Stochastic Rhythmic Fluctuation Trajectory via Machine Learning) framework for modeling long-term diabetes progression.
This comprehensive guide for researchers and drug development professionals explores the critical choice between microarray and sequencing platforms for DNA methylation profiling.
This article provides a comprehensive overview for researchers and drug development professionals on the integration of single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics to discover and validate metabolic biomarkers.
This article provides a comprehensive analysis of proteomic biomarkers for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), formerly known as NAFLD.
Metabolic dysfunction-associated fatty liver disease (MAFLD) is a leading cause of chronic liver disease worldwide, yet its molecular pathogenesis remains incompletely understood.
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on applying Mendelian Randomization (MR) to discover causal biomarkers for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
This article provides a comprehensive analysis of machine learning (ML) approaches for biomarker discovery in metabolic syndrome (MetS).
This article explores the transformative intersection of continuous glucose monitor (CGM) data and artificial intelligence (AI) for diabetes subtyping.
This article provides a comprehensive roadmap for researchers, scientists, and drug development professionals engaged in multi-omics biomarker discovery for metabolic disorders.